Locations
Cambridge, MA, USA · Waltham, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2017
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria. They offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis. Their innovative approach can also be expanded to provide new options for treating similar neurologically focused diseases including Parkinson's Disease (PD) and Alzheimer's Disease (AD). Lucy Therapeutics' unique approach recognizes that improvement of mitochondrial function early in disease will lead to disease modification as opposed to late-stage symptomatic treatments being pursued by many others. It proposes to focus on the orphan disease Rett Syndrome for a proof of concept. The Rett Syndrome (RTT) is a devastating pediatric disease, with no currently available drug treatments. Lucy Therapeutics was founded in 2017 and is based in Cambridge, Massachusetts, USA.
Something looks off?